JUV-112 / Juvena Therapeutics - LARVOL DELTA

JUV-112: A Novel Biologic for Sustaining Weight Loss and Enhancing Metabolism through Energy Expenditure (ENDO 2025) - "This ability to maintain weight, potentially driven by the sustained increase in energy expenditure, highlights JUV-112's potential as a novel approach for long-term weight management. Given its metabolic effects, JUV-112 may be an ideal candidate for combination therapies, potentially working with GIPR/GLP1R agonists to enhance overall metabolic health and prevent weight regain."

Genetic Disorders • Metabolic Disorders • Obesity